Pharmacists in Seekonk, MA Accepting Medicare

11 Pharmacists found. Showing 1 - 11

Dr. Michelle Cavanna, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 Fall River Ave, Seekonk, MA 02771 Phone: 508-336-5308

Mrs. Christine May Mcnaughton Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1479 Newman Ave, Seekonk, MA 02771 Phone: 508-399-8801

John L Mayo, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 Highland Ave, Seekonk, MA 02771 Phone: 508-336-4453    Fax: 508-336-6329

Jeanne Anne Beesmer Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 Fall River Ave, Seekonk, MA 02771 Phone: 508-336-5308

Mrs. Joyce Marie Sunderland, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 79 Commerce Way, T-1374, Seekonk, MA 02771 Phone: 508-336-1107    Fax: 508-336-1107

Mr. Andrew Demb Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1479 Newman Ave, Seekonk, MA 02771 Phone: 508-399-8801    Fax: 508-761-4323

Christopher Frank Anderson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 Highland Ave, Seekonk, MA 02771 Phone: 508-336-4453

Miss Mary Liem, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 79 Commerce Way, Seekonk, MA 02771 Phone: 508-336-1107

Bernadette Dagraca Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 134 Chelsea Dr, Seekonk, MA 02771 Phone: 508-558-5361

Dr. Amanda Briggs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 76 Willis Ave, Seekonk, MA 02771 Phone: 401-316-0448

Malynda Kelley Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1180 Fall River Ave, Seekonk, MA 02771 Phone: 508-336-5308

News Archive

Opexa Therapeutics reports lower net loss of $1.4M for first-quarter 2010

Opexa Therapeutics, Inc., a company developing Tovaxin®, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended March 31, 2010 and provided an update on its corporate developments.

Using cannabinoids for management of acute pain

A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain.

FDA approves LILETTA (levonorgestrel-releasing intrauterine system) to prevent pregnancy

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, today announced the approval of LILETTA (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration for use by women to prevent pregnancy for up to three years.

New York Times examines Russia's 'inadequate fight' against HIV/AIDS

Russia's HIV/AIDS epidemic "has defied worldwide trends, expanding more rapidly year by year than almost anywhere else," the New York Times writes in an article that examines how the country has become "one of the world's low points in the effort to fight the spread of HIV," in large part due to the government's failure to reach out to injecting drug users (IDUs) and sex workers - the groups "at the heart" of the epidemic.

Read more Medical News

› Verified 4 days ago